These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults. Thierry-Carstensen B, Jordan K, Uhlving HH, Dalby T, Sørensen C, Jensen AM, Heilmann C. Vaccine; 2012 Aug 10; 30(37):5464-71. PubMed ID: 22776216 [Abstract] [Full Text] [Related]
6. Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study. Kovac M, Kostanyan L, Mesaros N, Kuriyakose S, Varman M. Hum Vaccin Immunother; 2018 Mar 24; 14(8):1977-1986. PubMed ID: 29630439 [Abstract] [Full Text] [Related]
7. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. Kretsinger K, Broder KR, Cortese MM, Joyce MP, Ortega-Sanchez I, Lee GM, Tiwari T, Cohn AC, Slade BA, Iskander JK, Mijalski CM, Brown KH, Murphy TV, Centers for Disease Control and Prevention, Advisory Committee on Immunization Practices, Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep; 2006 Dec 15; 55(RR-17):1-37. PubMed ID: 17167397 [Abstract] [Full Text] [Related]
8. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP). Murphy TV, Slade BA, Broder KR, Kretsinger K, Tiwari T, Joyce PM, Iskander JK, Brown K, Moran JS, Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep; 2008 May 30; 57(RR-4):1-51. PubMed ID: 18509304 [Abstract] [Full Text] [Related]
9. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials. Weston WM, Friedland LR, Wu X, Howe B. Vaccine; 2012 Feb 21; 30(9):1721-8. PubMed ID: 22212127 [Abstract] [Full Text] [Related]
10. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine. Zepp F, Knuf M, Habermehl P, Mannhardt-Laakmann W, Howe B, Friedland LR. J Pediatr; 2006 Nov 21; 149(5):603-610. PubMed ID: 17095328 [Abstract] [Full Text] [Related]
11. Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults. Sirivichayakul C, Chanthavanich P, Limkittikul K, Siegrist CA, Wijagkanalan W, Chinwangso P, Petre J, Hong Thai P, Chauhan M, Viviani S. Hum Vaccin Immunother; 2017 Jan 02; 13(1):136-143. PubMed ID: 27686283 [Abstract] [Full Text] [Related]
12. Antibody persistence and safety and immunogenicity of a second booster dose nine years after a first booster vaccination with a reduced antigen diphtheria-tetanus-acellular pertussis vaccine (Tdap) in adults. Brandon D, Kimmel M, Kuriyakose SO, Kostanyan L, Mesaros N. Vaccine; 2018 Oct 08; 36(42):6325-6333. PubMed ID: 30197282 [Abstract] [Full Text] [Related]
14. Tetanus and pertussis vaccination coverage among adults aged ≥ 18 years --- United States, 1999 and 2008. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2010 Oct 15; 59(40):1302-6. PubMed ID: 20948508 [Abstract] [Full Text] [Related]
15. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2012 Jun 29; 61(25):468-70. PubMed ID: 22739778 [Abstract] [Full Text] [Related]
17. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA. Gidengil CA, Sandora TJ, Lee GM. Expert Rev Vaccines; 2008 Jul 29; 7(5):621-34. PubMed ID: 18564017 [Abstract] [Full Text] [Related]
20. Combined, reduced-antigen content tetanus, diphtheria, and acellular pertussis vaccine (Boostrix): a review of its use as a single-dose booster immunization in individuals aged 10-64 years in the US. Plosker GL. BioDrugs; 2009 Jul 29; 23(4):253-67. PubMed ID: 19697967 [Abstract] [Full Text] [Related] Page: [Next] [New Search]